Bolton NHS Foundation Trust

Specialist MDT: Salford Royal NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 230 1108
Performance Status recorded 84% 89%
PSA completed 80% 89%
Gleason Score completed 91% 84%
TNM completed 79% 86%

Disease Presentation

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men with disease status determined 1044 39897
Percentage of men diagnosed with metastatic disease 17% 17%

Management

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

Specialist MDT National
No. of men diagnosed with low-risk localised disease 156 4684
Percentage of men with low-risk localised disease receiving radical treatment 4% 8%
No. of men diagnosed with locally advanced disease 354 15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment 65% 68%